By correlating these biomarkers with EEG signals, MYndspan and EMOTIV can bring this clinical insight to the wearable market, enabling smarter, more personalized neurotechnological interventions.

Building on MYndspan's Crowdcube Campaign to Bring Clinical-Grade Brain Scanning to the Public LONDON, April 10, 2025 /PRNewswire/ - MYndsp ...

Exclusive real-time cognitive insights to better understand how your brain is functioning This partnership connects MYndspan's clinical-grade MEG assessments with EMOTIV's real-time EEG technology ...

LONDON, April 10, 2025 /CNW/ - MYndspan, the first company to offer clinical-grade MEG brain scanning to consumers, today announced a strategic investment from EMOTIV, a global leader in ...